ALVAC-CEA vaccine
Cancer vaccine
ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.[citation needed]
A phase I trial in 118 patients showed safety in humans.[1]
References
- ^ Kaufman, Howard L.; Lenz, Heinz-Josef; Marshall, John; Singh, Deepti; Garett, Chris; Cripps, Christine; Moore, Malcolm; von Mehren, Margaret; Dalfen, Richard; Heim, William J.; Conry, Robert M.; Urba, Walter J.; Benson, Al B.; Yu, Maria; Caterini, Judy; Kim-Schulze, Seunghee; Debenedette, Mark; Salha, Danielle; Vogel, Thorsten; Elias, Ileana; Berinstein, Neil L. (2008). "Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer". Clinical Cancer Research. 14 (15): 4843–4849. doi:10.1158/1078-0432.CCR-08-0276. PMID 18676757. S2CID 18152383.
External links
- ALVAC-CEA vaccine entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
- v
- t
- e
Artificial induction of immunity / Immunization: Vaccines, Vaccination, Infection, Inoculation (J07)
- Adjuvants
- Vaccine ingredients
- Mathematical modelling
- Storage
- Timeline
- Trials
Bacterial |
|
---|---|
Viral |
|
Protozoan |
|
Helminthiasis |
|
Other |
researchers
- General
- MMR (Lancet MMR autism fraud)
- NCVIA
- Pox party
- Thiomersal
- Vaccines and SIDS
- Cedillo v. Secretary of Health and Human Services
- Alternative vaccination schedule
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This oncology article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e